On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMay 31, 2023 9:45 am

Climate Clock is Ticking: NRDC Sees Urgency for Clean Power Now to Hit Net Zero Emission Goal

The world’s top polluters are on a mission to limit climate change to “well below” 2 degrees C, but time is moving quickly to meet goals over the next three decades GeoSolar Technologies offers a comprehensive, integrated package that heats, cools, and powers a home with 100% renewable energy A SmartGreen(TM) home includes rooftop solar system, geothermal heating and cooling technology, CERV air filtration, upgraded insulation, electric heat pump, EV charging station, and more The goal is clear: limit global warming to 1.5 degrees Celsius (2.7 degrees F). According to Climate Watch’s Net Zero Tracker, 91 countries, representing 95 countries…

Continue Reading

WednesdayMay 31, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Finalizes DehydraTECH(TM)-CBD Batch Manufacturing for IND Filing This Summer and FDA Phase 1b Trial Commencement in October 2023

Lexaria just announced the completion of batch manufacturing of its patented DehydraTECH(TM)-processed CBD and placebo materials for its FDA Phase 1b HYPER-H23-1 human clinical study This is in line with the company’s IND filing with the FDA, which it looks to complete this summer, with potential authorization within 60 days FDA authorization will mark the commencement of Phase 1b trial patient dosing, with the study evaluating the safety and tolerability of DehydraTECH-CBD in hypertensive patients Filling into capsules of the manufactured DehydraTECH-CBD is expected to be completed before the end of this month, after which analytical release and stability testing…

Continue Reading

TuesdayMay 30, 2023 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives Buy Rating and $70 Target Price; Releases Q1 2023 and Business Update

Analysts at Aegis Capital Corp. continue to recommend shares of the company with a Buy rating and a $70 target price Data from pre-clinical trial indicate that BiondVax’s NanoAb may effectively serve as both a therapeutic and protective prophylactic drug, further enhancing its value proposition BVXV reiterated further NanoAb development beginning with NanoAbs targeting immune system cytokines such as IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis BiondVax aims to optimize the use of assets and generate additional revenues by offering its drug development services and cGMP manufacturing capabilities to others BiondVax Pharmaceuticals (NASDAQ: BVXV),…

Continue Reading

TuesdayMay 30, 2023 11:15 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Positions Itself for Next-Gen Batteries with Strategic Move to Explore Complimentary Graphene Opportunities

As more and more consumers choose to curb their environmental input and governments prioritize decarbonization in a bid to fight climate change, the electric vehicle industry is gaining momentum; this achievement owes much to the progress made in critical minerals Graphene, a form of graphite that is just one atom thick, emerges as a wonder material with a wide range of potential uses; it is being explored as a potential replacement for traditional Li-ion batteries Poised to produce a critical mineral in America for American customers, Reflex aims to re-activate previous supply of graphite and has recently also made a…

Continue Reading

TuesdayMay 30, 2023 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Strengthens Position in Growing EV Market

The market for EVs has grown rapidly in recent years and is expected to continue growing at a fast pace over the coming decade MULN’s two manufacturing facilities are gearing up for increased production volume The company is meeting noteworthy milestones with each of its EV brands As the EV market steadily rises in the coming years, Mullen Automotive (NASDAQ: MULN) is positioning itself to be a strong player in the space. The Southern California–based automotive company recently released a corporate update outlining the impressive growth it has seen in the past few months (https://nnw.fm/wnSCL). “The market for electric vehicles…

Continue Reading

TuesdayMay 30, 2023 9:45 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Emerges as an Early Front-Runner Amidst RNG Sector ‘Gold-Rush’

Renewable Gas production has rapidly come into vogue, partially due to a wide array of tax credits provided to the sector under the auspices of the U.S.’ Inflation Reduction Act The push to develop RNG generation capacity has led to a spate of M&A within the sector, headlined by BP’s $4.1bn acquisition of Archaea Energy in late 2022 EverGen Infrastructure has been an early mover within the industry, with ambitious stated plans to own and manage 20 RNG-generating facilities across Canada within 5 years The company is seeking to capitalize on the exponential growth trends within the sector, which is…

Continue Reading

TuesdayMay 30, 2023 9:00 am

Starco Brands, Inc. (STCB) Disrupts CPG Industry with Aggressive M&A Strategy, Achieves Eye-Popping 1,060% YoY Revenue Growth

Starco Brands reported revenue of $7.8 million for the year ended December 31, 2022 – a YoY increase of 1,060% Starco Brands had revenues of $11.1 million Q1 of 2023, increasing 1,107% over the prior year period Leveraging an aggressive M&A strategy to disrupt the CPG industry, Starco Brands sparks excitement in the everyday Starco has completed the acquisition of three vertical-defining brands since Q3 2022, putting it on a run rate of roughly $67M in annual revenue Starco Brands (OTCQB: STCB) is a modern-day invention factory holding fast to its unwavering mission to invent and acquire consumer products and brands with…

Continue Reading

FridayMay 26, 2023 11:15 am

GSMI Talent Acquisition Week to Deliver the Most Comprehensive Learning Experience

Heads of talent acquisition, recruiters, and talent operations consultants are invited to attend the GSMI Talent Acquisition Week from July 17-21, 2023. The high-energy virtual event aims to bring together sourcing, recruiting, and talent acquisition strategies, to deliver the most comprehensive learning experience. The summit will provide insights into the latest trends of employer reputation, recruitment, approaching talent, sourcing, executive search, and more. It’s a great opportunity for attendees to meet industry leaders, learn the best practices in talent acquisition, and navigate through the hiring funnel. The post-pandemic job market calls for out-of-the-box sourcing, recruiting, and employer branding strategies. The…

Continue Reading

FridayMay 26, 2023 10:30 am

The Green Label Expo: Las Vegas 2023 Edition

The Green Label Expo 2023 edition will be held at the World Market Center in Las Vegas on the 13th & 14th of September, welcoming thousands of CBD experts, alternative product professionals, counterculture experts, and business owners to discover a vast array of global suppliers in trending sectors such as beauty, health & wellness, pet products, foods, business services, and more. As the need for embracing alternative products surges, the vibrant city of Las Vegas is set to welcome the largest trade show for CBD and alternative product professionals. This two-day event will feature an extensive showcase of innovative products/services,…

Continue Reading

FridayMay 26, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Shareholders Approve Board Appointments Amid Push for Diversity; Vote to Endorse 6 Agenda Items in 2023 Annual Shareholder Meeting

Lexaria held its virtual 2023 Annual Shareholders meeting on May 9, 2023 On the agenda were the election of six director nominees, the ratification of the appointment of the company’s independent registered public accounting firm, and the approval of a one-time repricing of specific issued stock options, among others All items presented received approval, with the highest approval percentage standing at 97.6% and the lowest at 63.1% The meeting presented an opportunity for Lexaria to evaluate areas of expertise that would provide additional benefits to the company and its shareholders while also adding diversity to its board Lexaria Bioscience (NASDAQ:…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217